Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Non-Current Debt (2023 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Non-Current Debt for 3 consecutive years, with $21.7 million as the latest value for Q3 2025.

  • Quarterly Non-Current Debt fell 15.46% to $21.7 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $21.7 million through Sep 2025, down 15.46% year-over-year, with the annual reading at $26.1 million for FY2024, 20.09% down from the prior year.
  • Non-Current Debt for Q3 2025 was $21.7 million at Werewolf Therapeutics, down from $24.7 million in the prior quarter.
  • The five-year high for Non-Current Debt was $39.1 million in Q2 2023, with the low at $21.7 million in Q3 2025.
  • Average Non-Current Debt over 3 years is $29.6 million, with a median of $26.6 million recorded in 2025.
  • The sharpest move saw Non-Current Debt tumbled 35.71% in 2024, then dropped 1.82% in 2025.
  • Over 3 years, Non-Current Debt stood at $32.7 million in 2023, then dropped by 20.09% to $26.1 million in 2024, then dropped by 17.01% to $21.7 million in 2025.
  • According to Business Quant data, Non-Current Debt over the past three periods came in at $21.7 million, $24.7 million, and $26.6 million for Q3 2025, Q2 2025, and Q1 2025 respectively.